Immediate Impact

58 standout
Sub-graph 1 of 23

Citing Papers

A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis
2024 Standout
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
2 intermediate papers

Works of D. Datta being referenced

HEART UK consensus statement on Lipoprotein(a): A call to action
2019
Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales
2015

Author Peers

Author Last Decade Papers Cites
D. Datta 279 117 114 20 354
Rutger Verbeek 323 156 127 16 400
Arjen J. Cupido 228 123 94 14 400
Claudia Morozzi 228 110 74 19 317
Pascal Pfister 221 45 45 12 350
Sven Bos 274 130 76 16 373
H.C. Geiss 182 57 154 12 308
Yuan-Lin Guo 193 129 100 19 342
Ying Gao 225 140 128 32 407
Ryozo Tatami 232 157 125 25 394
Anders Berg Wulff 272 144 223 20 389

All Works

Loading papers...

Rankless by CCL
2026